即时PCR(qPCR) 和数位 PCR (dPCR) 的全球市场

到 2030 年，全球即时PCR(qPCR) 和数位 PCR (dPCR) 市场规模将达到 84 亿美元

2024 年全球即时PCR（qPCR）和数位 PCR（dPCR）市场规模估计为 59 亿美元，预计到 2030 年将达到 84 亿美元，2024 年至 2030 年的复合年增长率为 6.1%。定量技术是报告中分析的细分市场之一，预计在分析期结束时复合年增长率为 5.7%，达到 76 亿美元。在分析期间内，数位技术领域的复合年增长率预计为 9.7%。

美国市场预计将达到 16 亿美元，中国市场年复合成长率将达到 9.8%

预计 2024 年美国即时PCR(qPCR) 和数位 PCR (dPCR) 市值将达到 16 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 19 亿美元，2024-2030 年分析期间的复合年增长率为 9.8%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 2.0% 和 6.4%。在欧洲，德国的复合年增长率预计为 3.2%。

即时PCR(qPCR) 和数位 PCR (dPCR)：主要趋势和驱动因素的总结

现代诊断中的即时PCR（qPCR）和数位 PCR（dPCR）有何不同？

即时PCR（qPCR）和数位 PCR（dPCR）是分子诊断领域的两种新兴技术，可在 DNA 和 RNA 的检测和定量方面提供高精度和高灵敏度，但在方法和应用上有着根本的不同。即时PCR，也称为定量 PCR (qPCR)，会扩增 DNA 序列并使用萤光染料或探针即时资料扩增产物的量。这种萤光使研究人员能够透过测量每个 PCR 循环期间的讯号强度来定量 DNA 目标，这使得它们对于病原体定量和基因表现分析等应用非常有用。相较之下，数位 PCR（dPCR）是一种新方法，它将 DNA 样本分成数千个小的单独反应，使得每个分裂可以包含或不包含 DNA 目标。扩增后，dPCR 对萤光呈阳性的分区进行计数，提供准确的绝对定量，而不需要 qPCR 所要求的标准曲线。

dPCR 的绝对定量能力使其成为需要高精度的应用的理想选择，例如检测肿瘤学中的低水平突变或评估慢性感染疾病中的病毒量。另一方面，qPCR 因其可扩展性、效率和既定的协议而变得广泛，尤其是在相对定量就足够的常规诊断中。儘管两种技术的用途不同，但它们在诊断方面往往相互补充，为病毒学、肿瘤学和遗传学等不同研究领域提供了以惊人的精度检测、测量和分析 DNA 的工具。

qPCR 和 dPCR 如何促进疾病检测和基因组学的进步？

qPCR 和 dPCR 在疾病检测和基因组学中发挥着至关重要的作用，可应用于感染疾病诊断、癌症研究、产前筛检等。例如，在 COVID-19 大流行期间，qPCR 已被用于大规模检测 SARS-CoV-2 感染，使公共卫生官员能够监测病毒的传播。同样，在肿瘤学中，qPCR 可用于测量肿瘤标记和监测治疗结果，其快速的周转时间是有益的。另一方面，dPCR 能够以高灵敏度量化罕见遗传事件，这使得它在检测低频突变方面非常有用，特别是在必须从少量血液样本中检测循环肿瘤 DNA 的液态切片中。

在基因组学研究中，dPCR的精准定量为基因编辑和基因治疗开闢了新的可能性。准确量化基因拷贝数和检测罕见基因突变对于研究品质和治疗效果至关重要。此外，dPCR 推动了非侵入性产前检测的发展，可以准确检测孕妇血液中的胎儿 DNA，从而减少了侵入性手术的需要。这种超灵敏技术对于监测微量残存疾病也非常有价值，并且可以在治疗后检测到甚至微量的肿瘤 DNA，提供復发的早期预警。 qPCR 和 dPCR 在基因组学研究中都有广泛的应用，可以发现罕见的遗传疾病、表观遗传学研究和药物基因组学。

哪些技术进步正在扩展 qPCR 和 dPCR 的功能？

自动化、多路復用和资料分析方面的创新正在突破 qPCR 和 dPCR 的极限，使其更快、更通用、更适合大规模应用。自动化简化了 qPCR 和 dPCR 工作流程，允许以最少的人工干预处理更大量的样本，这对于临床诊断和大规模研究非常重要。多重检测，即在单一反应中检测多个 DNA 目标，显着提高了 qPCR 和 dPCR 的效率，使研究人员能够同时分析多个基因或病原体。这种多路復用能力在传染病检查和肿瘤学等领域特别有用，因为全面的筛检对于制定有效的治疗计划至关重要。

小型化和携带式PCR 设备进一步提高了 qPCR 和 dPCR 在就地检验和现场诊断中的可及性。例如，手持设备可以在偏远地区和患者床边进行快速分子检测，这对于急性护理和在农村医疗保健环境中的及时诊断至关重要。软体和资料分析的改进也改变了 PCR资料的解释，人工智慧和机器学习演算法有助于优化结果、识别模式并对遗传和感染疾病提供更深入的见解。 PCR 技术的这些进步使得诊断应用更加广泛、反应时间更快、灵敏度更高，使得 qPCR 和 dPCR 能够适应分子诊断和基因组研究不断变化的需求。

是什么推动了即时PCR（qPCR）和数位 PCR（dPCR）市场的成长？

qPCR 和 dPCR 市场的成长受到精准诊断需求的不断增长、技术进步以及对个人化医疗日益关注的推动。 qPCR 和 dPCR 在对抗感染疾病中的重要性，正如它们在 COVID-19 检测中发挥的关键作用所示，凸显了全球对快速准确诊断的需求，并正在刺激市场扩张。在肿瘤学领域，精准医疗的兴起（根据个人的基因特征制定治疗方法）推动了对 qPCR 和 dPCR 等高精度、可量化工具的需求，以检测突变和监测治疗反应。此外，dPCR的绝对定量能力对于检测罕见突变和低水平病原体至关重要，并且是液态切片和早期癌症检测等应用所必需的。

同时，PCR 技术的创新，包括自动化、小型化和多路復用，使得 qPCR 和 dPCR 更加易于使用和高效，拓展了它们在临床诊断、环境监测和农业生物技术中的应用。基因研究的快速成长，尤其是基因治疗和基因组编辑，也增加了对 dPCR 的需求，因为研究人员需要精确的测量来评估基因改造的结果。此外，随着医疗保健提供者和消费者同样追求更多非侵入性诊断方法，qPCR 和 dPCR 的普及度持续增长，为产前筛检和早期癌症检测等非侵入性检测提供了可靠的解决方案。综合起来，这些趋势凸显了 qPCR 和 dPCR 在精准诊断、个人化治疗和高阶基因组分析中日益重要的作用，将这些技术定位为未来医疗保健和生物技术的基石。

部分

技术（定量、数位）、产品类型（消耗品和试剂、仪器、软体和服务）、应用（研究、临床、其他应用）

调查企业范例（共32家企业）

• Abbott Laboratories
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems
• Biomeme Inc.
• Biomerieux SA
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company Llc
• Danaher Corporation
• Elitech Group Sas
• Enzo Life Sciences, Inc.
• Eppendorf AG
• F. Hoffman-La Roche Ltd.
• Fluidigm Corporation
• JN Medsys
• Merck KGaA
• Meridian Bioscience, Inc.
• Promega Corporation
• Qiagen NV
• Quanta Biosciences Inc.
• Sacace Biotechnologies Srl
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

• 市场概况
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章 市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲国家
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market to Reach US$8.4 Billion by 2030

The global market for Real-time PCR (qPCR) and Digital PCR (dPCR) estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Quantitative Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$7.6 Billion by the end of the analysis period. Growth in the Digital Technology segment is estimated at 9.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.8% CAGR

The Real-time PCR (qPCR) and Digital PCR (dPCR) market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Real-Time PCR (qPCR) and Digital PCR (dPCR): Key Trends & Drivers Summarized

What Distinguishes Real-Time PCR (qPCR) from Digital PCR (dPCR) in Modern Diagnostics?

Real-time PCR (qPCR) and digital PCR (dPCR) are two advanced techniques in molecular diagnostics that offer high accuracy and sensitivity in detecting and quantifying DNA and RNA, yet they differ fundamentally in methodology and applications. Real-time PCR, also known as quantitative PCR (qPCR), amplifies DNA sequences and provides real-time data on the quantity of amplified product using fluorescent dyes or probes. This fluorescence allows researchers to quantify the DNA target by measuring signal intensity during each PCR cycle, making it highly useful in applications like pathogen quantification and gene expression analysis. In contrast, digital PCR (dPCR) is a newer method that partitions a DNA sample into thousands of tiny individual reactions, allowing each partition to either contain or not contain the DNA target. Following amplification, dPCR counts the partitions with positive fluorescence, offering precise, absolute quantification without the need for a standard curve, as required in qPCR.

The absolute quantification capability of dPCR makes it ideal for applications needing high precision, such as detecting low-level mutations in oncology or assessing viral loads in chronic infections. Meanwhile, qPCR remains widely popular due to its scalability, efficiency, and established protocols, particularly in routine diagnostics, where relative quantification is sufficient. Both technologies serve distinct purposes but often complement each other in diagnostics, offering tools to detect, measure, and analyze DNA with remarkable accuracy across diverse research areas, including virology, oncology, and genetics.

How Are qPCR and dPCR Driving Advances in Disease Detection and Genomics?

qPCR and dPCR are pivotal in disease detection and genomics, with applications spanning infectious disease diagnostics, cancer research, prenatal screening, and more. qPCR is especially valuable in infectious disease testing, where its rapid, quantitative capabilities enable timely diagnosis and management of pathogen loads. For example, during the COVID-19 pandemic, qPCR was instrumental in mass testing to detect SARS-CoV-2 infections, allowing public health authorities to monitor virus spread. Similarly, in oncology, qPCR assists in measuring tumor markers and monitoring treatment efficacy, where its fast turnaround time is beneficial. Meanwhile, dPCR’s ability to quantify rare genetic events with high sensitivity has made it invaluable in detecting low-frequency mutations, particularly useful in liquid biopsies, where circulating tumor DNA must be detected from a small blood sample.

In genomics research, dPCR’s precise quantification has opened new possibilities for gene editing and gene therapy, where accurately quantifying gene copies or detecting rare genetic variants is critical for research quality and therapeutic efficacy. Additionally, dPCR is advancing non-invasive prenatal testing, allowing for accurate detection of fetal DNA from maternal blood, reducing the need for invasive procedures. This ultra-sensitive technology is also invaluable in monitoring minimal residual disease in cancer, where even a trace amount of tumor DNA can be detected post-treatment, providing early warning signs of recurrence. Both qPCR and dPCR contribute extensively to genomic studies, enabling discoveries in rare genetic disorders, epigenetic research, and pharmacogenomics, thus driving precision medicine forward with accurate and actionable data.

What Technological Advancements Are Expanding qPCR and dPCR Capabilities?

Innovations in automation, multiplexing, and data analysis are pushing the boundaries of what qPCR and dPCR can achieve, making them faster, more versatile, and suitable for larger-scale applications. Automation has streamlined qPCR and dPCR workflows, allowing laboratories to handle higher sample volumes with minimal manual input, critical in clinical diagnostics and large-scale studies. Multiplexing, where multiple DNA targets are detected within a single reaction, has significantly improved testing efficiency in both qPCR and dPCR, enabling researchers to analyze multiple genes or pathogens simultaneously. This multiplexing capability is particularly valuable in fields like infectious disease testing and oncology, where comprehensive screening is essential for effective treatment planning.

Miniaturization and portable PCR devices have further enhanced accessibility, allowing qPCR and dPCR to be applied in point-of-care testing and field-based diagnostics. For example, handheld devices now make it possible to conduct rapid molecular testing in remote areas or at a patient’s bedside, which is essential for timely diagnostics in emergency and rural healthcare settings. Improvements in software and data analytics have also transformed PCR data interpretation, with artificial intelligence and machine learning algorithms helping to optimize results, identify patterns, and provide deeper insights into genetic and infectious diseases. These advancements in PCR technology enable broader diagnostic applications, faster response times, and greater sensitivity, making qPCR and dPCR adaptable to the evolving needs of molecular diagnostics and genomic research.

What Is Driving Growth in the Real-Time PCR (qPCR) and Digital PCR (dPCR) Market?

The growth in the qPCR and dPCR market is driven by increasing demand for precision diagnostics, technological advancements, and a rising focus on personalized medicine. qPCR and dPCR’s importance in the fight against infectious diseases, as evidenced by their pivotal role in COVID-19 testing, has highlighted the need for fast, accurate diagnostics worldwide, fueling market expansion. In oncology, the rise of precision medicine—where treatments are tailored based on individual genetic profiles—has spurred demand for highly accurate, quantifiable tools like qPCR and dPCR to detect mutations and monitor treatment responses. Additionally, dPCR’s absolute quantification capability makes it indispensable in detecting rare mutations or low-level pathogens, a necessity in applications like liquid biopsy and early-stage cancer detection.

In parallel, innovations in PCR technology, including automation, miniaturization, and multiplexing, are making qPCR and dPCR more accessible and efficient, broadening their applications in clinical diagnostics, environmental monitoring, and agricultural biotechnology. The rapid growth in genetic research, particularly in gene therapy and genome editing, has also increased demand for dPCR as researchers need precise measurements to assess gene modification outcomes. Furthermore, as healthcare providers and consumers alike push for more non-invasive diagnostic methods, qPCR and dPCR continue to grow in popularity, offering reliable solutions for non-invasive tests like prenatal screening and early cancer detection. Collectively, these trends underline the expanding role of qPCR and dPCR in precision diagnostics, personalized treatment, and modern genomics, positioning these technologies as cornerstones in the future of healthcare and biotechnology.

SCOPE OF STUDY:

The report analyzes the Real-time PCR (qPCR) and Digital PCR (dPCR) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Quantitative, Digital); Product Type (Consumables & Reagents, Instruments, Software & Services); Application (Research, Clinical, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems
• Biomeme Inc.
• Biomerieux S.A.
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company Llc
• Danaher Corporation
• Elitech Group Sas
• Enzo Life Sciences, Inc.
• Eppendorf AG
• F. Hoffman-La Roche Ltd.
• Fluidigm Corporation
• JN Medsys
• Merck KGaA
• Meridian Bioscience, Inc.
• Promega Corporation
• Qiagen N.V.
• Quanta Biosciences Inc.
• Sacace Biotechnologies Srl
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Real-time PCR (qPCR) and Digital PCR (dPCR) - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Demand for Precision Diagnostics Drives Adoption of Real-Time PCR (qPCR) and Digital PCR (dPCR) in Clinical Testing
  • Rising Prevalence of Infectious Diseases Spurs Use of qPCR and dPCR for Rapid and Accurate Pathogen Detection
  • Expansion of Genetic Research and Genomic Studies Propels Demand for qPCR and dPCR in Molecular Biology Labs
  • Increasing Focus on Cancer Research Boosts Adoption of dPCR for High-Sensitivity Mutation Detection and Liquid Biopsy Applications
  • Technological Advancements in PCR Instrumentation Improve Accuracy and Speed of qPCR and dPCR Testing
  • Growing Use of qPCR and dPCR in Agricultural Biotechnology Expands Market for Crop and Livestock Genetic Testing
  • Rising Demand for Companion Diagnostics in Personalized Medicine Drives Market for qPCR and dPCR in Targeted Therapy
  • Increasing Need for Rapid COVID-19 and Other Viral Testing Enhances Adoption of qPCR as a Gold Standard
  • Development of Multiplex PCR Techniques Expands Application Scope for qPCR and dPCR in Multi-Target Testing
  • Adoption of qPCR and dPCR in Environmental Monitoring Strengthens Market for Pollution and Water Quality Testing
  • Rising Awareness of Antimicrobial Resistance Spurs Use of qPCR and dPCR in Antibiotic Resistance Monitoring
  • Increased Use of qPCR and dPCR in Food Safety Testing Expands Market for Pathogen and Allergen Detection in Food Products
  • Growing Focus on Biomarker Discovery for Chronic Diseases Boosts Adoption of qPCR and dPCR in Diagnostic Research
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Real-time PCR (qPCR) and Digital PCR (dPCR) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Quantitative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Quantitative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Quantitative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Digital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Real-time PCR (qPCR) and Digital PCR (dPCR) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Quantitative and Digital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Technology - Percentage Breakdown of Value Sales for Quantitative and Digital for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Consumables & Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Product Type - Percentage Breakdown of Value Sales for Consumables & Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Research, Clinical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Real-time PCR (qPCR) and Digital PCR (dPCR) by Application - Percentage Breakdown of Value Sales for Research, Clinical and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION